Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 4 | 2022 | 114 | 1.010 |
Why?
|
| Urology | 1 | 2023 | 28 | 0.830 |
Why?
|
| Nephroureterectomy | 1 | 2018 | 1 | 0.620 |
Why?
|
| Ureteral Neoplasms | 1 | 2018 | 4 | 0.610 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 5 | 0.610 |
Why?
|
| Flank Pain | 1 | 2018 | 8 | 0.610 |
Why?
|
| Hematuria | 1 | 2018 | 20 | 0.600 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 24 | 0.600 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2022 | 75 | 0.470 |
Why?
|
| Urothelium | 3 | 2020 | 22 | 0.370 |
Why?
|
| Urologic Neoplasms | 2 | 2020 | 12 | 0.340 |
Why?
|
| Catheter Ablation | 1 | 2022 | 141 | 0.180 |
Why?
|
| Cytogenetic Analysis | 1 | 2020 | 24 | 0.180 |
Why?
|
| Urine | 1 | 2020 | 36 | 0.180 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 190 | 0.170 |
Why?
|
| Carcinoma | 1 | 2020 | 117 | 0.170 |
Why?
|
| Kidney Pelvis | 1 | 2019 | 6 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 137 | 0.160 |
Why?
|
| Ureter | 1 | 2019 | 20 | 0.160 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 139 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 262 | 0.160 |
Why?
|
| Ureteroscopy | 1 | 2018 | 3 | 0.150 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2018 | 28 | 0.150 |
Why?
|
| Frailty | 1 | 2020 | 126 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 908 | 0.150 |
Why?
|
| Protein Subunits | 1 | 2018 | 164 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 193 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 272 | 0.140 |
Why?
|
| Risk-Taking | 1 | 2018 | 159 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 466 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 268 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2018 | 296 | 0.140 |
Why?
|
| Cystitis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 685 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 579 | 0.130 |
Why?
|
| Eosinophilia | 1 | 2016 | 29 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2016 | 36 | 0.130 |
Why?
|
| Eosinophils | 1 | 2016 | 53 | 0.130 |
Why?
|
| Kidney | 1 | 2018 | 397 | 0.130 |
Why?
|
| Hemangioma | 1 | 2016 | 28 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 1481 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 278 | 0.110 |
Why?
|
| Mutation | 1 | 2020 | 2466 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2018 | 1936 | 0.090 |
Why?
|
| Middle Aged | 3 | 2019 | 16542 | 0.070 |
Why?
|
| Humans | 8 | 2022 | 60081 | 0.070 |
Why?
|
| Biopsy | 2 | 2019 | 375 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2022 | 5266 | 0.060 |
Why?
|
| Female | 4 | 2019 | 31226 | 0.060 |
Why?
|
| Microwaves | 1 | 2022 | 14 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 302 | 0.040 |
Why?
|
| Urinalysis | 1 | 2020 | 33 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 76 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 61 | 0.040 |
Why?
|
| Microscopy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Aged | 3 | 2020 | 13596 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 45 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 49 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 177 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 230 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1037 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2016 | 94 | 0.030 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1100 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1565 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 850 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2016 | 188 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 161 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2016 | 460 | 0.030 |
Why?
|
| Male | 3 | 2019 | 27951 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2360 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 15972 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1839 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5200 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6147 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 2049 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7622 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 5944 | 0.020 |
Why?
|